Caricamento...
Immune escape and immunotherapy of acute myeloid leukemia
In spite of the recent approval of new promising targeted therapies, the clinical outcome of patients with acute myeloid leukemia (AML) remains suboptimal, prompting the search for additional and synergistic therapeutic rationales. It is increasingly evident that the bone marrow immune environment o...
Salvato in:
| Pubblicato in: | J Clin Invest |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Clinical Investigation
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7108895/ https://ncbi.nlm.nih.gov/pubmed/32235097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI129204 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|